Skip to main content
. 2023 Aug 30;41(2):81–108. doi: 10.1097/EJA.0000000000001876
Recommendation 3.4 Quality of the evidence Strength of recommendation
We do not suggest using biomarkers to identify patients at risk of POD. Low Weak